Results summary | View all lists in L2L MDB | View all genes in S02B.profile.ud50 |
Up-regulated 4 hr following treatment of human microvessel endothelial cells (HMVEC) with TGFbeta. enrichment: 1.62-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
210236_AT | PPFIA1 | C | S | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 | |||||||||
204427_S_AT | TMED2 | T | transmembrane emp24 domain trafficking protein 2 | ||||||||||
206544_X_AT | SMARCA2 | G | R | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | |||||||||
206543_AT | SMARCA2 | G | R | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | |||||||||
212663_AT | FKBP15 | P | FK506 binding protein 15, 133kDa | ||||||||||
217202_S_AT | GLUL | C | glutamate-ammonia ligase (glutamine synthetase) | ||||||||||
203373_AT | SOCS2 | G | S | suppressor of cytokine signaling 2 | |||||||||
214845_S_AT | CALU | calumenin | |||||||||||
212593_S_AT | PDCD4 | G | R | programmed cell death 4 (neoplastic transformation inhibitor) | |||||||||
210153_S_AT | ME2 | E | malic enzyme 2, NAD(+)-dependent, mitochondrial | ||||||||||
222024_S_AT | AKAP13 | S | A kinase (PRKA) anchor protein 13 | ||||||||||
221617_AT | TAF9B | R | TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor, 31kDa | ||||||||||
201324_AT | EMP1 | G | D | epithelial membrane protein 1 | |||||||||
201341_AT | ENC1 | D | ectodermal-neural cortex (with BTB-like domain) | ||||||||||
205097_AT | SLC26A2 | T | solute carrier family 26 (sulfate transporter), member 2 | ||||||||||
215220_S_AT | TPR | T | translocated promoter region (to activated MET oncogene) |